|Podcasts|November 11, 2021
Episode 95: CEOs Share Their Industry Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Advertisement
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
2
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals
3
FDA Approves Foundayo Under National Priority Voucher Program
4
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
5